Aadi bioscience announces approval of all proposals at special meeting of stockholders

Morristown, n.j. , march 3, 2025 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer treatment, today announced that the company's stockholders have approved all proposals voted on at the company's special meeting of stockholders ("special meeting") held on february 28, 2025.
AADI Ratings Summary
AADI Quant Ranking